[May 20, 2013] Ariad Pharmaceuticals Earnings Hindsight: Down 5.0% in Last 13 Days (ARIA) Tweet May 20, 2013 (SmarTrend(R) News Watch via COMTEX) -- 13 days ago, on May 7th, 2013, Ariad Pharmaceuticals (NASDAQ:ARIA) reported its earnings. Analysts, on average, expected a loss of $0.37 per share on sales of $5.0 million. The company actually reported a loss of $0.36 per share on sales of $6.5 million, beating EPS estimates by $0.01 and beating revenue estimates by $1.4 million. Since the company's report, shares of Ariad Pharmaceuticals have fallen from $17.55 to $16.67, representing a loss of 5.0% in the past 13 days. In the past 52 weeks, Ariad Pharmaceuticals share prices have been bracketed by a low of $15.13 and a high of $25.40 and are now at $16.67, 10% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 2.2%. SmarTrend recommended that its subscribers protect gains by selling shares of Ariad Pharmaceuticals on March 25th, 2013 by issuing a Downtrend alert when the shares were trading at $18.89. Since that call, shares of Ariad Pharmaceuticals have fallen 11.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]